资讯

GEN - Genetic Engineering and Biotechnology News3 天
Novel Leukemia Target Found in RNA-Binding Cell Surface Protein
Researchers show that glycoRNAs, uncovered by the lab of Nobel Laureate, Carolyn Bertozzi, can be used to fight cancer.
Science Daily2 天
Leukemia News
Apr. 11, 2025 — A multi-institutional team developed a chimeric antigen receptor (CAR) T cell-based strategy for specifically targeting AML cells in patients who relapsed following other treatments.
Medscape3 天
Acute Myeloid Leukemia Stem Cells: Seek and Destroy
Acute myeloid leukemia (AML) remains incurable for the majority of patients. AML originates from a rare population of cells, termed leukemic stem cells (LSCs) or leukemia-initiating cells ...
A new druggable cancer target: RNA-binding proteins on the cell surface
In 2021, research led by Ryan Flynn, MD, Ph.D., and his mentor, Nobel laureate Carolyn Bertozzi, Ph.D., opened a new chapter ...
mskcc.org3 天
A New Cellular Immunotherapy Approach May Offer Treatment for AML and MDS
The blood cancers acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS ... Now laboratory research, published online April 23, in Cell, shows it may be possible to develop an ...
Cancer Research5 天
Abstract 6933: Ru(II)-thymine complex inhibits NF-κB activation, suppressing acute myeloid ...
Search for other works by this author on: ...
AB Science announces that EMA granted orphan drug status to AB8939 for the treatment of ...
HAS GRANTED ORPHAN DRUG DESIGNATION IN THE EUROPEAN UNION FOR AB8939 IN THE TREATMENT OF ACUTE MYELOID LEUKEMIA Paris, April 23, 2025, 6.45pm CET AB Science SA (Euronext - FR0010557264 - AB) announces ...